Dysfunctional HDL as a Therapeutic Target for Atherosclerosis Prevention
- 21 May 2019
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 26 (9) , 1610-1630
Abstract
Hypercholesterolemia is one of the main risk factors for the development of atherosclerosis. Among the various lipoprotein classes, however, high density lipoproteins (HDL) are inversely associated with the incidence of atherosclerosis, since they are able to exert a series of atheroprotective functions. The central role of HDL within the reverse cholesterol transport, their antioxidant and anti-inflammatory properties and their ability to preserve endothelial homeostasis are likely responsible for HDL-mediated atheroprotection. However, drugs that effectively raise HDL-C failed to result in a decreased incidence of cardiovascular event, suggesting that plasma levels of HDL-C and HDL function are not always related. Several evidences are showing that different pathologic conditions, especially those associated with an inflammatory response, can cause dramatic alterations of HDL protein and lipid cargo resulting in HDL dysfunction. Established and investigational drugs designed to affect lipid metabolism and to increase HDL-C are only partly effective in correcting HDL dysfunction.Keywords
This publication has 214 references indexed in Scilit:
- Effect of dalcetrapib plus pravastatin on lipoprotein metabolism and high-density lipoprotein composition and function in dyslipidemic patients: Results of a phase IIb dose-ranging studyAmerican Heart Journal, 2012
- The Anti-Oxidative Capacity of High-Density Lipoprotein Is Reduced in Acute Coronary Syndrome But Not in Stable Coronary Artery DiseaseJACC, 2011
- Impact of HDL oxidation by the myeloperoxidase system on sterol efflux by the ABCA1 pathwayJournal of Proteomics, 2011
- The complexity of HDLBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- Abnormal function of high‐density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritisArthritis & Rheumatism, 2009
- Dysfunctional proinflammatory high‐density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosusArthritis & Rheumatism, 2009
- Statins induce S1P1 receptors and enhance endothelial nitric oxide production in response to high‐density lipoproteinsBritish Journal of Pharmacology, 2007
- Effects of Extended-Release Niacin on Lipoprotein Particle Size, Distribution, and Inflammatory Markers in Patients With Coronary Artery DiseaseThe American Journal of Cardiology, 2006
- Glycated High-Density Lipoprotein Induces Apoptosis of Endothelial Cells via a Mitochondrial DysfunctionBiochemical and Biophysical Research Communications, 2001
- Lipids and risk of coronary heart disease The Framingham StudyAnnals of Epidemiology, 1992